No Data
No Data
H.C. Wainwright Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $73
Buy Rating for Legend Biotech: Strategic Expansion and Increased CARVYKTI Production Forecasted to Alleviate Supply Constraints and Drive Growth
Express News | HC Wainwright & Co. Reiterates Buy on Legend Biotech, Maintains $73 Price Target
Express News | Legend Biotech Corp: Anticipates 55 Full-Time Employees Will Eventually Be Based in Philadelphia Facility
Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
Today's Pre-Market Movers and Top Ratings | LI, BABA, NKE and More